Highlights from the AWS Healthcare and Life Sciences Executive Symposium 2023 at re:Invent

The article summarizes the highlights from the AWS Healthcare and Life Sciences (HCLS) Executive Symposium 2023 held at re:Invent. It focuses on harnessing the power of data, analytics, machine learning (ML), and generative AI to accelerate innovation in healthcare and life sciences.

Specifically, the article covers:

• Highlights from the opening keynote, emphasizing the importance of a solid, end-to-end data strategy as the key to building powerful ML and generative AI applications
• Part 1: Leveraging data and analytics to scale innovation, featuring insights from organizations like Genomics England, Bristol Myers Squibb, Inovalon, and Boehringer Ingelheim on building robust data foundations on AWS
• Part 2: ML and generative AI in healthcare and life sciences, showcasing AWS's comprehensive AI and ML capabilities, including Amazon Bedrock, and customer use cases from Genentech (Roche) and Radiology Partners
• Conclusion: Responsible and secure development of generative AI solutions, with insights from Anthropic, Baxter, and Deloitte on establishing guardrails and promoting AI as a force for good